We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

What Should the Targeted Range of Blood Glucose Levels Be to Reduce the Incidence of Surgical Site Infection Following General Surgery?

Kazuhiro Hanazaki, MD, PhD; Takehiro Okabayashi, MD, PhD
Arch Surg. 2011;146(3):368-369. doi:10.1001/archsurg.2011.16.
Text Size: A A A
Published online


We read with great interest the article by Ata et al.1 The authors concluded that postoperative hyperglycemia may be the most important risk factor for surgical site infection (SSI) and that aggressive early postoperative glycemic control (ie, a glucose level of <140 mg/dL [to convert to millimoles per liter, multiply by 0.0555]) should reduce the incidence of SSI. Perioperative hyperglycemia in critically ill surgical patients is the main risk factor for the development of postoperative infection, which is a common, and often costly, surgical complication.2 Results from our own prospective randomized clinical trials suggest that tight perioperative glycemic control using an artificial endocrine pancreas (with a targeted range of blood glucose levels of 80-110 mg/dL) in either hepatectomized3 or pancreatectomized4 patients significantly reduces the incidence of SSI compared with conventional insulin therapy (with a targeted range of blood glucose levels of 150-200 mg/dL). On the basis of these findings, tight perioperative glycemic control may be a key factor in reducing the incidence of postoperative infections, including SSI, and thus in reducing morbidity and mortality after general surgery.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





March 1, 2011
Ashar Ata, MBBS, MPH; Steven C. Stain, MD
Arch Surg. 2011;146(3):370. doi:10.1001/archsurg.2011.19.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

3 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles